InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001104659-23-009973 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-02 2023-02-01 ALT Garg Vipin K Pres, CEO, Dir M - OptEx $0.00 +16.5K 246.3K +7% $0
D 2023-02-02 2023-02-01 ALT Garg Vipin K Pres, CEO, Dir F - Tax $13.78 -7,658 238.6K -3% -$105.5K
D 2023-02-02 2023-01-31 ALT Garg Vipin K Pres, CEO, Dir A - Grant $10.21 +1,938 229.7K +0.9% +$19.8K
D 2023-02-02 2023-02-01 ALT Garg Vipin K Pres, CEO, Dir M - OptEx $0.00 -16.5K 33.1K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2023-02-01 M A 16,546 $0.00 246,259 D — — (F3) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
2 Common Common Stock, par value $0.0001 2023-02-01 F D 7,658 $13.78 238,601 D — —
3 Common Common Stock, par value $0.0001 2023-01-31 A A 1,938 $10.21 229,713 D — — (F2) In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2022.
4 Derivative Restricted Stock Units 2023-02-01 M D 16,546 $0.00 33,090 D — · — to — 16,546 Common Stock, par value $0.0001 (F3) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F5) The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.